Table 3.
Adjusted* HR | 95% CI | |
CRC incidence† | ||
Gender | ||
Male | 1.00 | – |
Female | 0.84 | 0.79 to 0.89 |
Age at time of FIT (years) | ||
50–59 | 1.00 | – |
60–69 | 1.7 | 1.59 to 1.80 |
Screening round | ||
First | 1.00 | – |
Subsequent | 0.5 | 0.47 to 0.53 |
Compliance with colonoscopy | ||
Yes | 1.00 | – |
No (up to month 6) | 0.56 | 0.51 to 0.61 |
No (beyond month 6) | 3.68 | 3.20 to 4.22 |
CRC mortality‡ | ||
Gender | ||
Male | 1.00 | – |
Female | 0.68 | 0.56 to 0.81 |
Age at time of FIT (years) | ||
50–59 | 1.00 | – |
60–69 | 1.88 | 1.56 to 2.26 |
Screening round | ||
First | 1.00 | – |
Subsequent | 0.45 | 0.37 to 0.54 |
Compliance with colonoscopy | ||
Yes | 1.00 | – |
No | 2.03 | 1.68 to 2.44 |
*Adjusted by all the variables reported in the table.
†According to Extended-Cox model.
‡According to Cox model.
CRC, colorectal cancer; FIT, faecal immunochemical test.